We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

45 hedge funds and large institutions have $34.2M invested in Cumberland Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 9

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

9% more capital invested

Capital invested by funds: $31.4M → $34.2M (+$2.82M)

0% more funds holding

Funds holding: 45 → 45 (0)

Holders
45
Holders Change
–
Holders Change %
0%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
5
Increased
16
Reduced
9
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$351K
2
Renaissance Technologies
Renaissance Technologies
New York
+$189K
3
PM
Platinum Management
New York
+$127K
4
Deutsche Bank
Deutsche Bank
Germany
+$63.2K
5
AIS
AlphaOne Investment Services
Pennsylvania
+$50.3K

Top Sellers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
-$2.68M
2
GHA
GW Henssler & Associates
Georgia
-$513K
3
UCFA
United Capital Financial Advisors
Texas
-$426K
4
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
-$300K
5
BIT
BlackRock Institutional Trust
California
-$84.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
Ariel Investments
Illinois
$12.5M -$2.68M -521,825 -20%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$5.1M +$4.35K +847 +0.1%
Millennium Management
3
Millennium Management
New York
$3.85M +$351K +68,433 +12%
BIT
4
BlackRock Institutional Trust
California
$2.76M -$84.4K -16,436 -3%
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.68M +$39.5K +7,700 +3%
New York State Common Retirement Fund
6
New York State Common Retirement Fund
New York
$1.44M -$300K -58,500 -20%
Renaissance Technologies
7
Renaissance Technologies
New York
$723K +$189K +36,800 +44%
GHA
8
GW Henssler & Associates
Georgia
$693K -$513K -100,000 -46%
BA
9
Bard Associates
Illinois
$531K -$3.08K -600 -0.7%
BCM
10
Bridgeway Capital Management
Texas
$504K – – –
UCFA
11
United Capital Financial Advisors
Texas
$433K -$426K -82,956 -53%
Morgan Stanley
12
Morgan Stanley
New York
$373K +$334 +65 +0.1%
GCP
13
GSA Capital Partners
United Kingdom
$354K – – –
California Public Employees Retirement System
14
California Public Employees Retirement System
California
$322K – – –
Invesco
15
Invesco
Georgia
$322K – – –
Geode Capital Management
16
Geode Capital Management
Massachusetts
$285K +$1.22K +237 +0.5%
BFA
17
BlackRock Fund Advisors
California
$267K +$16.4K +3,186 +8%
Jacobs Levy Equity Management
18
Jacobs Levy Equity Management
New Jersey
$260K -$9.75K -1,900 -4%
AIS
19
AlphaOne Investment Services
Pennsylvania
$235K +$50.3K +9,800 +33%
PP
20
PDT Partners
New York
$192K – – –
SIM
21
Spark Investment Management
New York
$181K +$20K +3,900 +15%
Acadian Asset Management
22
Acadian Asset Management
Massachusetts
$162K – – –
Northern Trust
23
Northern Trust
Illinois
$148K +$1.27K +248 +1%
PM
24
Platinum Management
New York
$148K +$127K +24,800 New
Norges Bank
25
Norges Bank
Norway
$134K – – –
1
2

CPIX Hedge Fund Activity: Q4 2014 in Review

45 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2014, worth a combined $34.2M — up 9% from $31.4M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new CPIX positions and 3 closed out — a net gain of 2 holders — while 16 added to existing stakes and 9 trimmed.

The largest buyer was Millennium Management, adding an estimated $351K. The largest seller was Ariel Investments, cutting an estimated $2.68M.

  • 45 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $34.2M of Cumberland Pharmaceuticals stock for Q4 2014, up 9% quarter-over-quarter.
  • 5 funds opened new Cumberland Pharmaceuticals positions in Q4 2014 and 3 closed out, a net change of +2 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q4 2014 was Millennium Management, an estimated $351K added.
  • The largest Cumberland Pharmaceuticals seller in Q4 2014 was Ariel Investments, an estimated $2.68M sold.

Based on aggregated 13F filings for Q4 2014.